Highlight Capital

Hongpu Technology is a high-tech company that independently develops advanced instruments and provides technology solutions. It designs and manufactures precision sensing and analytical systems for industrial monitoring and safety applications, including infrared optics, intelligent robotics, gas leak detection, temperature measurement, and spectral analysis technologies. The organization emphasizes modular hardware, real-time data acquisition, and multi-environment adaptability to serve energy, metallurgy, transportation, and environmental protection sectors, with the goal of enhancing operational safety, improving diagnostic accuracy, and supporting automated inspection workflows.

Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Zhongqing Robotics is a pioneering company specializing in the development of general-purpose intelligent robots. It focuses on comprehensive research and development, integrating collaborative software and hardware innovations to create full-stack robotic technology. The company aims to serve the broader robotics industry by providing cutting-edge, industry-specific solutions.

Methuselah Medical Technology is an enterprise specializing in medical nutrition technology. It integrates research, development, production, and sales, focusing on creating tailored nutritional solutions. The company has produced four series of medical nutrition products, including 'Youkangli' and 'Youyili', along with various biscuits, noodles, powders, teas, and moon cakes designed to meet specific nutritional needs. Methuselah partners strategically in the U.S., aiming to provide nutrition products suited to the Chinese population's unique characteristics.

Jiamai specializes in the manufacture of precision pneumatic components. It mainly develops and produces precision slide cylinders, pneumatic fingers, digital pressure sensors, and other pneumatic components. Their products are widely used in LCD, OLED, smartphones, lasers, lithium batteries, and other consumer electronics equipment.

Shengfang Technology is a high-tech company that combines sales, service, production, and research and development for excimer lasers.

TOYA specializes in the production of ultra-fine copper and copper alloy conductors.

Meditip Company is a consulting firm focused on healthcare licensing, catering to both domestic and global medical markets. The company specializes in the development and commercialization of bioproducts and medical devices, utilizing a comprehensive approach that includes licensing, insurance, clinical support, aftercare, distributor identification, and preliminary market research. By leveraging extensive information, knowledge, and experience, Meditip guides its clients in navigating the complexities of the healthcare industry, ensuring reliable access to medical solutions worldwide.

Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.

Zhongqing Robotics is a pioneering company specializing in the development of general-purpose intelligent robots. It focuses on comprehensive research and development, integrating collaborative software and hardware innovations to create full-stack robotic technology. The company aims to serve the broader robotics industry by providing cutting-edge, industry-specific solutions.

ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.

Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Wuxi Gongwang inductive sensor developer offering high-precision, oil and dust-resistant products for various industries, including aerospace, automotive, medical care, and more.

MCT (Milli Intelligence) is an innovative company that specializes in intelligent space-time sensing chips and solutions. It is dedicated to providing top-tier products and services to consumers in autonomous driving, intelligent robotics, IoT, shared travel, digital twins, vertical industries, and other areas.

EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.

Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.

Hydropeng Technology is a company that developes solid oxide fuel cell specializes in the engineering development of solid oxide fuel cells (SOFC) and electrolytic cells (SOEC). Hydropeng Technology applies its extensive R&D capabilities in materials, chemistry, mechanics, and other fields to create efficient hydrogen energy systems that fulfill the green energy demands of global ESG development.

Aoli Biotechnology is a biopharmaceutical oral delivery technology provider. Aoli Biotechnology focuses on research into macromolecule oral delivery technology and has developed a number of world-leading excipient technology patents, including soteria and phloral technology.

Tachem is a biotechnology company that develops, produces, and distributes a range of products derived from the protected amino acid series. These products cater to diverse industries, including medical, healthcare, food, and cosmetics, among others. Tachem's primary offerings comprise protective amino acids, non-natural amino acids, and high-quality chemical raw materials, serving as biotechnical solutions for various industrial users.

Hongce Precision is a company that specializes in providing inspection solutions for wafer-level chips. It has developed a range of products, including various types of probe cards, LOAD BOARDS, and IC aging test boards. The company focuses on inspecting panel driver chips, image sensor chips, logic chips, and other application scenarios, offering diverse solutions to its clients.

Stand Group provides diversified testing and R&D services to national and global markets in health, economic, and social development fields.

Viva Biotech Holdings is a Shanghai-based company that specializes in structure-based drug discovery services for biotechnology and pharmaceutical clients worldwide. Founded in 2008, the company offers a comprehensive range of research and development services, including fragment-based drug discovery and advanced screening technologies such as affinity selection mass spectrometry and cryo-electron microscopy. Viva Biotech provides various products, including cell lines, crystal structures, GPCR proteins, and antibodies, alongside services in medicinal chemistry, in vitro pharmacology, and antibody discovery. The company operates as an integrated drug discovery platform, combining its expertise in early-stage drug research with contract development and manufacturing services for small molecule active pharmaceutical ingredients and intermediates. Its innovative approach and advanced technological platforms position Viva Biotech as a valuable partner in the global drug development landscape.

Acchrom, also known as Huapu Instrument (Beijing) Technology Co., Ltd., is a prominent company specializing in chromatography, offering comprehensive solutions that include products, technical services, and support. The company's focus is on chromatographic separation products designed to effectively separate mixtures. Acchrom emphasizes a closed-loop system that integrates chromatography equipment, consumables, software, and customer services, thereby enabling clients to conduct chromatographic separation analysis efficiently. The company is dedicated to establishing itself as a well-known national brand in chromatography and has developed targeted marketing strategies and a professional sales team across key provinces to enhance its marketing network and presence in the industry.

Rgenta Therapeutics, Inc. is a biotechnology company focused on developing RNA-targeting medicines aimed at treating oncology and neurological disorders. Founded in 2018 and based in Cambridge, Massachusetts, the company utilizes a proprietary platform that analyzes extensive genomic data to identify targetable RNA processing events. This innovative approach enables the design of small-molecule glues that modulate interactions among the spliceosome, regulatory proteins, and RNAs. Rgenta's unique methodology aims to unlock the therapeutic potential of previously undruggable targets, ultimately advancing drug development for human diseases.

Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

Hongyixin is an automotive electronic chip developer.

Etana is a biotechnology company dedicated to the production and sale of biopharmaceuticals, particularly focusing on oncology and other life-threatening diseases. The company specializes in the development and commercialization of biological drugs, including biosimilars, aimed at serving Indonesia and other emerging markets. Etana's operations encompass research and development, manufacturing, and marketing of advanced medical treatments, such as recombinant gene technology and monoclonal antibody drugs. By prioritizing affordability, Etana strives to provide patients with access to essential medicines and vaccines.

ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

Base Therapeutics is focused on developing innovative cell and gene editing technologies to address cancerous diseases. The company has created a natural killer cell genetic engineering platform, along with various cell therapy products aimed at treating several types of cancer, including lung cancer, liver cancer, glioma, and other hematological tumors. Through its advanced technologies, Base Therapeutics aims to enhance the safety and effectiveness of clinical applications of gene editing, both in vivo and in vitro, providing healthcare professionals with improved treatment options for patients suffering from these serious conditions.

LePure Biotech, established in 2011 and headquartered in Shanghai, China, operates within the biotechnology and pharmaceutical sectors. The company specializes in the development and manufacturing of disposable biopharmaceutical process equipment and consumables, primarily focusing on products that facilitate the storage, transportation, filling, and leak detection of samples related to biosimilars, vaccines, and other biopharmaceutical applications. Its core offering is a disposable storage bag designed to meet the specific needs of these processes. Recently, LePure Biotech completed a B+ round of financing, which aims to fund the development of innovative products, establish a research and development center in the United States, enhance supply chain integration, and expand its R&D operations both domestically and internationally.

Etana is a biotechnology company dedicated to the production and sale of biopharmaceuticals, particularly focusing on oncology and other life-threatening diseases. The company specializes in the development and commercialization of biological drugs, including biosimilars, aimed at serving Indonesia and other emerging markets. Etana's operations encompass research and development, manufacturing, and marketing of advanced medical treatments, such as recombinant gene technology and monoclonal antibody drugs. By prioritizing affordability, Etana strives to provide patients with access to essential medicines and vaccines.

Silicon Innovation is a technology company based in Chengdu, China, established in December 2019. The company specializes in developing high-end interconnect chip solutions, focusing on analog and digital-analog hybrid chips tailored for clocks, interfaces, and power management. Silicon Innovation's products cater primarily to the enterprise sector, supporting critical applications in data centers, 5G communications, artificial intelligence, autonomous driving, intelligent monitoring, and the Internet of Things. By providing advanced chip technologies, the company enables businesses across various industries to enhance their systems and products, driving innovation in a rapidly evolving technological landscape.

Bebest Automotive Electronics specializes in the production and research of advanced automotive electronic products. The company focuses on developing intelligent chassis core components and chassis domain controllers, which are essential for modern vehicle systems. Additionally, Bebest offers technical services related to autonomous driving, as well as electronic mechanical brake systems and steering-by-wire systems. By providing high-quality solutions for chassis-by-wire technology, Bebest aims to meet the growing demands of the global automotive market.

Yaotan Pharmaceutical offers one-stop CDMO services for the research and production of raw materials and preparations CMC, covering the formulation process development, quality research, registration, and declaration of chemical raw materials and preparations, as well as for customers. They adhere to the unique concept and original aim of assisting the globe in the discovery and development of novel drugs. They are committed to establishing a service platform for small-molecule medication research and development.

MediLink Therapeutics is a biotechnology company with a research and development center located in Suzhou, China. The company specializes in the development of next-generation antibody-drug conjugates (ADCs) aimed at treating cancer more effectively. MediLink Therapeutics is dedicated to addressing significant unmet medical needs within China and seeks to create global value through multicenter clinical trials and cross-border collaborations. By focusing on ADC therapeutics, the company aims to provide cancer patients with treatments that target cancerous cells while minimizing harm to healthy cells, thereby enhancing patient well-being during treatment.

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

TopOlefin Technology specializes in the research, development, and production of advanced polymer materials, with a focus on high-end optical resins. The company is dedicated to creating products characterized by high transparency, high refractive index, and strong gas barrier properties. These innovative materials find applications across various industries, including optical lenses, medical packaging, and consumer packaging. By prioritizing green and intelligent design, TopOlefin Technology aims to deliver high-quality resin solutions that meet the diverse needs of its clients.

SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.

ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Inmagene Biopharmaceuticals Co. Ltd. is a Shanghai-based biopharmaceutical company founded in 2019, specializing in the research and pre-clinical development of therapies for immunology-related diseases. The company focuses on creating innovative drug candidates that address unmet medical needs globally, employing a strategy known as "Borderless Innovation." Inmagene has developed a diverse pipeline, including IMG-020, a protein drug designed to target IL-17A, which utilizes a combination of Affibody's protein therapeutics platform and Albumod technology to enhance potency and extend half-life. In addition to IMG-020, the company boasts several clinical-stage assets and multiple preclinical candidates aimed at improving pharmacokinetic and pharmacodynamic properties, safety profiles, and dosing convenience for patients. With additional offices in Hangzhou and Beijing, Inmagene is dedicated to advancing drug development through cutting-edge technology and a commitment to global collaboration in the fight against immunological diseases.

Chongxing Chongwu is a supplier of pet supplies.

Hope Medicine is a biopharmaceutical company focused on researching, developing, and commercializing innovative drugs to enhance the quality of life for various common male and female diseases. The company specializes in translational medicine and aims to address significant health challenges by leveraging global research initiatives. Hope Medicine is engaged in the development of monoclonal antibodies, protein-based therapies, and other drug formulations targeting endocrine, cardiovascular, and metabolic diseases. Through its efforts, the company seeks to provide underserved patient populations with access to effective and affordable treatments, ultimately improving their health outcomes.

Zonsen Peplib Biotech builds a peptide compound library and provides peptide drug discovery and development services for global pharmaceutical and biotech companies. The company's technology could compress the amino acid sequence information of about 500,000,000 peptides into 80,000 peptide compounds.

Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.

Artivila Therapeutics is a pharmaceutical company based in Shenzhen, China, founded in 2018. It specializes in the research and development of new drugs, focusing on therapeutic solutions for neurodegenerative diseases, cancers, and autoimmune diseases. The company leverages an AI-powered drug discovery engine to create an innovative platform that enables the consistent and efficient development of first-in-class molecules. Artivila Therapeutics aims to enhance patients' lives through advanced biotechnology and targeted therapeutics.

Biotheus Inc. is a biotechnology company based in Zhuhai, China, founded in 2018. The company specializes in the development and commercialization of innovative biologics, focusing primarily on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Biotheus is dedicated to addressing malignant tumors and autoimmune diseases by researching and developing next-generation multispecific antibodies. The company explores the mechanisms of regulatory T cells and innate immunity to create antibody-based therapeutics that enhance immune therapy and provide effective treatments for cancer and metabolic disorders.

Novast is a multinational pharmaceutical company focused on the research, development, and manufacture of value-added and complex dosage forms, including controlled-release and other advanced drug-delivery systems. With operations in China and the United States, it partners with pharmaceutical and biotechnology companies to develop and commercialize products for regulated markets, providing product development services and leveraging proprietary technologies. The company emphasizes designing formulations for challenging APIs and global markets, supported by cGMP manufacturing capabilities and quality systems. It also engages in contract research, development, and quality control to support clients in achieving regulatory approval and efficient market access. Through its drug-delivery platforms and comprehensive development capabilities, Novast aims to improve access to affordable, high-quality medications while expanding its international footprint.

Imago BioSciences, Inc. is a clinical-stage biotechnology company based in Redwood City, California, founded in 2012. The company specializes in developing novel small molecule therapeutics aimed at treating hematologic diseases, including myelodysplastic syndromes, acute myelogenous leukemia, and other conditions associated with bone marrow failure. Central to its research is the enzyme lysine-specific demethylase 1 (LSD1), which is involved in the regulation of blood cell production. Imago BioSciences is focused on translating advanced scientific insights into transformative therapies that can alter the course of disease, thereby enhancing the quality and longevity of life for patients. Its lead product candidate, Bomedemstat, is an orally administered LSD1 inhibitor currently under evaluation for its potential to modify disease progression in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers.

Xingyun Group specializes in transforming the digital supply chain for consumer goods, offering comprehensive Direct-to-Consumer (DTC) services. The company employs whole-process SaaS tools to enhance the global commodity trade environment. Its Management Middle-end System Services Engine integrates industrial ecological resources, facilitating cost reduction and efficiency improvements through data utilization. Xingyun Group supports overseas consumer brands in entering the Chinese market while assisting Chinese brands in their global expansion efforts. The platform boasts nearly 160 cooperative and self-operated warehouses across 72 countries and one region, catering to over 350,000 online and offline retailers in China. Its product offerings include maternal and child supplies, beauty care, healthcare, digital products, clothing, and shoes, ensuring reliable and cost-effective purchasing solutions for domestic retailers.

Gaugene is a high-tech enterprise that specializes in the development and supply of hematology testing instruments, reagents, and services tailored for in vitro diagnostic (IVD) users. The company offers advanced instruments and reagents that play a critical role in hematology diagnosis, as well as broader clinical diagnostics and life science research. Gaugene is notable for being the only manufacturer in China that incorporates high-power flow lasers and high-sensitivity multi-color fluorescence detection systems in its products. This technological edge enables the company to provide innovative solutions for clinical diagnosis, flow cytometry technology, single cell research, protein screening, and the discovery of new clinical indicators. Gaugene is co-sponsored by experienced professionals from renowned domestic IVD companies, ensuring a strong foundation in industry-leading technologies.

Soocas (Shenzhen) Technology Co., Ltd., founded in 2015, is an Internet technology company focused on personal digital health care products. The company emphasizes independent research and development to create advanced, intelligent, and high-quality products. Its primary offerings include the Soocas sonic electronic toothbrush and a mobile application that enhances user experience. As part of Xiaomi's ecosystem, Soocas benefits from a team with extensive experience in product design and development, drawn from notable companies such as Huawei, Oral-B, and Philips. The brand's flagship product, the X3 sonic electronic toothbrush, is backed by numerous patents in the field. With a commitment to the principles of passion, focus, and excellence, Soocas aims to continually improve its personal care products, which also include blow dryers and shaving razors.

Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices. Specializing in minimally invasive treatments for mitral valve regurgitation, the company’s flagship product is the Valve Clamp, an interventional device designed to assist in the closure of heart valves during surgical procedures. By focusing on innovative solutions for heart valve diseases, Hanyu Medical aims to enhance surgical outcomes and patient recovery through its advanced medical technologies.

Novast is a multinational pharmaceutical company focused on the research, development, and manufacture of value-added and complex dosage forms, including controlled-release and other advanced drug-delivery systems. With operations in China and the United States, it partners with pharmaceutical and biotechnology companies to develop and commercialize products for regulated markets, providing product development services and leveraging proprietary technologies. The company emphasizes designing formulations for challenging APIs and global markets, supported by cGMP manufacturing capabilities and quality systems. It also engages in contract research, development, and quality control to support clients in achieving regulatory approval and efficient market access. Through its drug-delivery platforms and comprehensive development capabilities, Novast aims to improve access to affordable, high-quality medications while expanding its international footprint.

ChosenMed is a healthcare company specializing in oncology precision medicine, primarily concentrating on early tumor screening and companion diagnosis. The company develops innovative oncology products aimed at the early detection, prevention, and diagnosis of tumors. ChosenMed emphasizes the guidance of targeted medication for solid tumors and the prediction of the efficacy of tumor immunotherapy. By offering a comprehensive suite of precision medical and immunotherapy solutions, the company seeks to enhance patient outcomes in the field of oncology.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

4inLook is a retailer specializing in color contact lenses, operating over 300 stores across first- and second-tier cities in China. Founded in 2008 and based in Shanghai, the company offers more than 200 distinct designs tailored primarily for women aged 18 to 30. In addition to its brick-and-mortar presence, 4inLook has expanded its reach through online channels, including a Tmall store, providing a seamless shopping experience that integrates online ordering with offline product trials and pick-up options. The company focuses on enhancing the aesthetic appeal of its customers' eyes while making cosmetic products accessible and affordable.

Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

Ennovabio is a Chinese drug development company focused on creating cancer therapies, including drugs targeting brain glioma, with a Shanghai base. It specializes in targeted therapies and immunotherapy candidates and develops proprietary platforms to overcome drug resistance, aiming to improve clinical outcomes and expand treatment options for patients with high medical needs.

Genetron Health is a leading precision medicine company specializing in oncology, with a strong focus on cancer molecular profiling. The company leverages advanced technologies in molecular biology and data science to enhance cancer treatment. Genetron Health offers comprehensive health management products covering all aspects of full-cycle cancer clinical treatment, including risk assessment, early screening, molecular pathology diagnosis, medication guidance, and prognosis monitoring. They provide reliable molecular clinical services and professional cancer genetic risk assessments for patients and high-risk individuals. With global genomics sequencing and bioinformatics platforms, research and development centers in North Carolina and Beijing, and clinical laboratories across major Chinese cities, Genetron Health aims to expand its sales network throughout China. The company is dedicated to serving both Chinese and global cancer patients with its expertise in cancer genomics and efficient clinical translation.

Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

Verseau Therapeutics, Inc. is a biotechnology company focused on developing macrophage checkpoint modulators to address cancer, immune, and inflammatory diseases. Established in 2017 and headquartered in Lexington, Massachusetts, the company aims to create a new class of therapeutics that can modulate macrophage behavior. By identifying novel targets, Verseau's therapies are designed to facilitate a shift in macrophages from immune suppressors to activators, enhancing the effectiveness of immunotherapy for patients. Through this innovative approach, Verseau Therapeutics seeks to improve treatment outcomes for individuals suffering from various diseases.

Julikang is a third-party medical device disinfection service provider focused on the healthcare industry, catering to numerous hospitals across China. The company specializes in sterilization and disinfection services, utilizing automated single and multi-chamber cleaning devices to ensure thorough sanitization of medical items and environments. Julikang enhances its service efficiency through the integration of its sterile item traceability management software with hospital information systems, allowing for real-time access to equipment manufacturer data. This capability enables effective traceability management of sterile articles, ensuring compliance and quality in disinfection processes.

Loving Care International Pet Hospital is a comprehensive animal medical institution that operates a chain of clinics and hospitals focused on pet healthcare services. The facility offers a range of services including beauty treatments, physical examinations, vaccinations, and clinics. In addition to standard medical care, Loving Care provides users with information on the prevention of common diseases in dogs and cats, as well as alternative pet health issues. The establishment also operates mobile animal service vehicles to deliver home-based basic medical services, ensuring that pets receive the care they need in a convenient manner. Through its commitment to improving the diagnosis and treatment of pet diseases, including serious conditions such as tumors, Loving Care aims to enhance the overall well-being of animals and support pet owners in maintaining their pets' health.

Angstrom STEM is a brand of Anglia Education Group, integrating the resources and achievements of science and technology education of Shanghai Jiaotong University, and introducing the technology experience model of the United States and Canada, innovatively opening up STEM entertainment and education, integrating scientific experiments, model construction, mechanical energy, robot construction With programming, 3D printing, mathematics, etc., and focusing on the application and innovation of the latest science and technology, we have established a complete scientific STEM curriculum system to promote the quality education of domestic children and build a leading high-end STEM education brand in China.

Bitwise is a crypto-specialist asset manager serving individuals, investment managers, and institutions seeking exposure to the cryptocurrency market. The firm offers a broad platform of investment solutions focused on crypto assets, including cryptocurrency index funds and single-asset funds designed to be liquid, low-cost, and secure. It provides yield and alpha strategies, multi-strategy approaches, and separately managed accounts, as well as onchain staking and bitcoin-related investment products, enabling clients to access opportunities aligned with their objectives. By combining specialized crypto expertise with rigorous risk controls, Bitwise acts as a specialist partner that helps diverse investors navigate the crypto space with rules-based exposure and efficient administration.

NewDoon is a research, development, and manufacturing company of life science products and solutions. It is a company that develops neuroscience products and solutions. They have developed wireless optogenetics systems, fiber photometry systems, and miniaturized fluorescence microscopy.

Cullgen Inc. is a clinical-stage biopharmaceutical company developing small molecule therapeutics based on its uSMITE platform, which enables targeted protein degradation by using novel E3 ligands to selectively degrade disease-causing proteins. The approach aims to address cancers, inflammatory and autoimmune diseases, and other conditions lacking effective therapies. Founded in 2018 and based in San Diego, Cullgen's pipeline includes degrader programs such as TRK and GSPT1, as well as other candidates like DAC.

Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on the research and development of biocatalytic and synthetic biology methods, aiming for their application in large-scale production. Its innovations are utilized across various sectors, including pharmaceuticals, agriculture, and food, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a leader in bio-intelligent manufacturing and the development of chemical and biological products.

Imago BioSciences, Inc. is a clinical-stage biotechnology company based in Redwood City, California, founded in 2012. The company specializes in developing novel small molecule therapeutics aimed at treating hematologic diseases, including myelodysplastic syndromes, acute myelogenous leukemia, and other conditions associated with bone marrow failure. Central to its research is the enzyme lysine-specific demethylase 1 (LSD1), which is involved in the regulation of blood cell production. Imago BioSciences is focused on translating advanced scientific insights into transformative therapies that can alter the course of disease, thereby enhancing the quality and longevity of life for patients. Its lead product candidate, Bomedemstat, is an orally administered LSD1 inhibitor currently under evaluation for its potential to modify disease progression in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers.

Boholo is a digital medical management company based in Shanghai, China, established in 2011. It offers an integrated platform that combines various digital medicine tools, including software for clinical case management, three-dimensional surgical modeling, and multimedia case databases. The company's advanced medical imaging technology utilizes artificial intelligence and machine vision to create precise 3D anatomical models, which assist healthcare professionals in planning and preparing for surgical procedures. Additionally, Boholo provides a comprehensive service platform that supports specialists globally through software tools, departmental services, and communication assistance, enhancing the overall quality of medical treatment.

BrightGene Bio-Medical Technology Company is a biopharmaceutical firm based in Suzhou, China, specializing in the research, development, manufacturing, and commercialization of innovative medicines and high-quality generic active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). The company has a diverse product pipeline that includes immuno-oncological agents, GLP-1 receptor agonists for type 2 diabetes, and antibody-drug conjugates aimed at treating solid tumors and brain cancers. Additionally, BrightGene develops a variety of treatments such as Eribulin, Trabectedin, and various macromolecules and cytotoxic payloads. Its product offerings span multiple therapeutic areas, including oncology, cardiology, infectious diseases, and immunology. Founded in 2001, BrightGene has positioned itself as a leader in small molecules and nucleotide drugs, focusing on advancing therapeutics across all stages of development.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

VCBeat is a company based in Chongqing, China, founded in 2014, that operates an online platform focused on delivering news and insights within the healthcare sector. It specializes in media coverage and industry research, offering valuable data and resources aimed at healthcare professionals, investors, and the general public. Through its comprehensive service platform, VCBeat integrates industry communication and consulting services tailored for healthcare entrepreneurs, facilitating industry research and resource access. The company's mission is to provide in-depth information and analysis on the future developments in the healthcare industry, positioning itself as a key player in the dissemination of relevant knowledge and trends in this field.

ZQ Automotive is a company focused on automotive electronics and human-machine voice interaction technology. It develops intelligent voice-based hardware and software solutions designed for automobile systems. The company’s innovations include car voice hardware that facilitates human-computer voice interaction, allowing users to engage in various in-car activities. These features encompass in-car voice-based learning, maintenance booking during promotional periods, in-car payment functionalities, and leisure and entertainment services. Through these advancements, ZQ Automotive aims to enhance the driving experience by providing users with a safer and more enjoyable environment while on the road.

Biotheus Inc. is a biotechnology company based in Zhuhai, China, founded in 2018. The company specializes in the development and commercialization of innovative biologics, focusing primarily on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Biotheus is dedicated to addressing malignant tumors and autoimmune diseases by researching and developing next-generation multispecific antibodies. The company explores the mechanisms of regulatory T cells and innate immunity to create antibody-based therapeutics that enhance immune therapy and provide effective treatments for cancer and metabolic disorders.

MALO CLINIC was established in 1995 by Dr. Paulo Malo. Today is world’s leader in Implantology and Dental Cosmetic as well as an Educational Centre on Oral Rehabilitation that trains over 3,500 professionals coming from all over the world per year. Besides Dentistry MALO CLINIC expanded to other health specialties, projecting an innovative concept of Medical Spa through a strong bet in wellbeing which resulted in the foundation of a Health Management business group spread worldwide known as MALO CLINIC Health & Wellness.

Predicine Huidu Medical Technology Co., Ltd., based in Fengxian, China, specializes in the research and development of technologies for cancer diagnosis and monitoring. The company focuses on developing gene detection methods and bioinformatics algorithms, which enable healthcare companies to enhance tumor diagnosis and treatment. By connecting patients and healthcare providers through its clinical application platform, Predicine Huidu Medical Technology aims to advance the field of oncology and improve patient outcomes.

Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its service offerings encompass clinical inspection instruments, various types of auxiliary reagents, technical support, management and certification, as well as the operation of independent medical laboratories. Chemclin is committed to introducing advanced diagnostic products and services to the Chinese market, thereby enhancing the capabilities of clinical diagnostics in the region.

Gaugene is a high-tech enterprise that specializes in the development and supply of hematology testing instruments, reagents, and services tailored for in vitro diagnostic (IVD) users. The company offers advanced instruments and reagents that play a critical role in hematology diagnosis, as well as broader clinical diagnostics and life science research. Gaugene is notable for being the only manufacturer in China that incorporates high-power flow lasers and high-sensitivity multi-color fluorescence detection systems in its products. This technological edge enables the company to provide innovative solutions for clinical diagnosis, flow cytometry technology, single cell research, protein screening, and the discovery of new clinical indicators. Gaugene is co-sponsored by experienced professionals from renowned domestic IVD companies, ensuring a strong foundation in industry-leading technologies.

Chowsing Live is an online retailer based in Shanghai, China, specializing in pet products and accessories. The company focuses on creating innovative and practical items that meet the needs of pets and their owners, fostering a natural and harmonious lifestyle. Its product range includes pet jumbo wipes, cat collars with bells, and flushable cat litters, all designed with an emphasis on design and creativity. By addressing the specific needs of pet-raising families, Chowsing Live aims to enhance the pet ownership experience through thoughtfully developed products.

MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

ChosenMed is a healthcare company specializing in oncology precision medicine, primarily concentrating on early tumor screening and companion diagnosis. The company develops innovative oncology products aimed at the early detection, prevention, and diagnosis of tumors. ChosenMed emphasizes the guidance of targeted medication for solid tumors and the prediction of the efficacy of tumor immunotherapy. By offering a comprehensive suite of precision medical and immunotherapy solutions, the company seeks to enhance patient outcomes in the field of oncology.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

Kunya Medical is a provider of medical equipment management services, specializing in the maintenance, installation, and repair of hospital medical equipment. The company offers comprehensive outsourcing solutions that enhance the efficiency of medical equipment management within hospitals, thereby extending the lifecycle of critical clinical devices. Kunya Medical caters to both domestic and international brands of large and medium-sized medical equipment, delivering services such as technical maintenance, equipment relocation, installation, and debugging. Additionally, the company supplies a full range of spare parts and equipment management software, ensuring that hospitals can effectively manage their medical assets.

Junhetang is a prominent operator of traditional Chinese medicine clinics, specializing in a range of therapies and healthcare services. The company has established a network of clinics that provide traditional Chinese medicines, including herbal medicine, acupuncture, massage, and dietary therapies. By integrating TCM culture with the expertise of renowned practitioners, Junhetang aims to offer personalized medical services that cater to individual health needs. Additionally, the company leverages convenient internet services to enhance its healthcare management and service delivery. Headquartered in Nanjing, Junhetang is actively expanding its presence across various cities in China, including Shanghai, Shenzhen, Chengdu, and Taiyuan, thereby broadening access to traditional Chinese medicine for a wider audience.

Chongxing Chongwu is a supplier of pet supplies.

Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

Sansure Biotech Inc. is a biotechnology company based in Changsha, Hunan Province, established in 2008. The company specializes in molecular diagnosis and genetic testing, developing and manufacturing a range of products that include nucleic acid extraction kits, real-time polymerase chain reaction (PCR) diagnostic kits, and fluorescence systems. Its product portfolio encompasses diagnostic kits for various health concerns, including novel coronavirus detection, viral hepatitis, AIDS, cancer biomarkers, and respiratory, digestive, and genetic diseases. Additionally, Sansure Biotech provides instruments and consumables to support its diagnostic offerings. The company primarily serves hospitals and laboratories both in China and internationally, focusing on enhancing diagnostic capabilities across multiple medical fields.

Loving Care International Pet Hospital is a comprehensive animal medical institution that operates a chain of clinics and hospitals focused on pet healthcare services. The facility offers a range of services including beauty treatments, physical examinations, vaccinations, and clinics. In addition to standard medical care, Loving Care provides users with information on the prevention of common diseases in dogs and cats, as well as alternative pet health issues. The establishment also operates mobile animal service vehicles to deliver home-based basic medical services, ensuring that pets receive the care they need in a convenient manner. Through its commitment to improving the diagnosis and treatment of pet diseases, including serious conditions such as tumors, Loving Care aims to enhance the overall well-being of animals and support pet owners in maintaining their pets' health.

Ennovabio is a Chinese drug development company focused on creating cancer therapies, including drugs targeting brain glioma, with a Shanghai base. It specializes in targeted therapies and immunotherapy candidates and develops proprietary platforms to overcome drug resistance, aiming to improve clinical outcomes and expand treatment options for patients with high medical needs.

WinnTi Medical creates medical devices through continuous product innovations and manufacturing improvements, meeting surgeons' increasing demands, and improving patients' wellness.

General Healthy is a company based in Shanghai that specializes in pharmaceutical logistics automation and mobile medical solutions. It offers a range of products and services designed for the intelligent management of medicines within the medical services and pharmaceutical circulation sectors. The company's focus is on enhancing efficiency and accuracy in the handling and distribution of pharmaceuticals, thereby improving overall healthcare delivery.

Xiao Qu Hao Hushi provides online medical consultancy services through an application.

Rundo Medical is a contract research organization (CRO) that focuses on providing comprehensive clinical research outsourcing services to pharmaceutical and biotechnology companies. It specializes in a range of high-quality solutions, including clinical operations, medical data management, biostatistics, and medical project management. As a prominent player in the CRO industry, Rundo Medical is a key initiator and promoter of the China CRO Alliance. The company has distinguished itself by being the first in its sector to achieve ISO 9001:2008 quality management system certification, combined with CRO industry standard certification. Through its professional services, Rundo Medical supports various clients in advancing their medical research and operational objectives.

Siyuans Aviation Tech is a technology enterprise focused on the aerospace industry, specializing in the development and manufacturing of equipment for airport operations. The company produces intelligent maintenance systems for airport navigation lights and offers various essential components, including fragile parts, integrated cabins, and multi-functional security wells designed for flight areas. By providing integrated traffic control and runway lighting solutions, Siyuans Aviation Tech enables airports to enhance their operational efficiency and safety through advanced technology.

Cui Yutao Children Health Management Center is focused on the development of a comprehensive platform for children's physical and mental health management. The center provides an integrated mobile application that facilitates daily health tracking, online parenting community interactions, and access to expert guidance in pediatrics. This application also offers medical assistance and child health insurance services, designed to equip parents with essential resources and information for effective childcare. Through its online and offline services, Cui Yutao aims to enhance the overall well-being of children by offering up-to-date advice on medical care, early-stage education, and infant product recommendations.

Xanthus Media is an animation production company. They involve in presenting audio-visual feasts and conveying emotional value. Screenwriting, designing, special effects, strategic consulting, management, and marketing are the business line of this company.